Sebastian Gatica1,2, Felipe Eltit3,4, Juan F Santibanez5,6, Diego Varela7,8, Claudio Cabello-Verrugio1,2,9, Felipe Simon1,2. 1. Departamento de Ciencias Biologicas, Facultad de Ciencias de la Vida, Universidad Andres Bello, 8370146, Santiago, Chile. 2. Millennium Institute on Immunology and Immunotherapy, 8331150, Santiago, Chile. 3. Department of Materials Engineering, University of British Columbia, Vancouver, Canada. 4. School of Biomedical Engineering, University of British Columbia, Vancouver, Canada. 5. Department of Molecular Oncology, Institute for Medical Research, University of Belgrade, Belgrade, Serbia. 6. Centro Integrativo de Biología y Química Aplicada (CIBQA). Universidad Bernardo O'Higgins, Santiago, Chile. 7. Programa de Fisiología y Biofísica, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile. 8. Millennium Nucleus of Ion Channels-Associated Diseases (MiNICAD), Universidad de Chile, Chile. 9. Center for the Development of Nanoscience and Nanotechnology (CEDENNA), Universidad de Santiago de Chile, Santiago, Chile.
Authors: Ivanka Jimenez; Yolanda Prado; Felipe Marchant; Carolina Otero; Felipe Eltit; Claudio Cabello-Verrugio; Oscar Cerda; Felipe Simon Journal: Cells Date: 2020-12-04 Impact factor: 6.600